A case report of severe acute pancreatitis with infected necrosis and concomitant Coronavirus Disease‑19 (COVID‑19): a nosocomial infection or delayed respiratory manifestation of viral disease?

Authors

DOI:

https://doi.org/10.30978/GS-2021-1-42

Keywords:

acute necrotizing pancreatitis, SARS‑CoV‑2, COVID‑19

Abstract

The association between COVID‑19 and acute pancreatitis (AP) has been extensively analyzed in recent research and review papers worldwide. It should be noted that most studies have focused on AP as a COVID‑19 complication and/or an extra‑pulmonary manifestation of the disease, although the investigation reports on the cases of prior pancreatitis and subsequent COVID‑19 infection are limited.

The aim of this case report is to describe the treatment protocol and clinical outcome of a patient with acute necrotizing pancreatitis who developed nosocomial COVID‑19..

Case presentation. The data were collected from patient S., a 42‑year‑old male admitted with AP to the intensive care unit of Kyiv City Clinical Emergency Hospital, in October 2020. This study was reviewed and approved by the local Ethics Committee (Protocol No 25‑15‑60). The patient signed written informed consent to participate in the study, after having been informed of all relevant aspects that could influence his decision.

The patient, primarily diagnosed with AP, was admitted to the hospital without a PCR test for detecting SARS‑CoV‑2. 21 days after his admission to the hospital, the patient developed COVID‑19. AP progression to severe AP with infected necrosis, the development of systemic inflammatory response syndrome and multiple organ failure necessitated operative pancreatic debridement, which was postponed due to severe acute respiratory failure. Operative pancreatic debridement was performed on the 45th day of hospital stay after the resolution of COVID‑19‑associated pneumonia. The postoperative period was typical for the disease severity and the extent of the surgery, and was complicated by external pancreatic and colonic fistulas. The length of hospital stay for this patient was 115 days which included 20 days of treatment and monitoring in the intensive care unit due to pneumonia. He was discharged after clinical symptom improvement.

Conclusions. It is imperative to screen patients presenting with AP for SARS‑CoV‑2 in order to avoid misdiagnosis and inappropriate treatment strategy. Further detailed investigation of mechanisms of pancreatic injury in patients with SARS‑CoV‑2 is necessary.

 

References

Al-Harmi RAR, Fateel T, Sayed Adnan J, AlAwadhi K. Acute pancreatitis in a patient with ­COVID‑19. BMJ Case Rep. 2021 Feb 11;14(2):e239656. doi: 10.1136/bcr-2020-239656.

Alves AM, Yvamoto EY, Marzinotto MAN, Teixeira ACS, Carrilho FJ. SARS‑CoV‑2 leading to acute pancreatitis: an unusual presentation. Braz J Infect Dis. 2020 Nov-Dec;24(6):561-4. doi: 10.1016/j.bjid.2020.08.011.

Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779.

Bulthuis MC, Boxhoorn L, Beudel M, et al. Acute pancreatitis in ­COVID‑19 patients: true risk? Scand J Gastroenterol. 2021 May;56(5):585-7. doi: 10.1080/00365521.2021.1896776.

Correia de Sá T, Soares C, Rocha M. Acute pancreatitis and ­COVID‑19: A literature review. World J Gastrointest Surg. 2021 Jun 27;13(6):574-84. doi: 10.4240/wjgs.v13.i6.574.

Ding L, Yang Y, Li H, Wang H, Gao P. Circulating lymphocyte subsets induce secondary infection in acute pancreatitis. Front Cell Infect Microbiol. 2020 Mar 31;10 : 128. doi: 10.3389/fcimb.2020.00128.

Dirweesh A, Li Y, Trikudanathan G, Mallery JS, Freeman ML, Amateau SK. Clinical outcomes of acute pancreatitis in patients with coronavirus disease 2019. Gastroenterology. 2020 Nov;159(5):1972-4. doi: 10.1053/j.gastro.2020.07.038.

Elhence A, Mahapatra SJ, Vajpai T, Garg PK. Acute pancreatitis and nosocomial ­COVID‑19: Cause specific host responses may determine lung injury. Pancreatology. 2020 Oct;20(7):1258-61. doi: 10.1016/j.pan.2020.08.008.

Galanopoulos M, Gkeros F, Doukatas A, et al. ­COVID‑19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020 Aug 21;26(31):4579-88. doi: 10.3748/wjg.v26.i31.4579.

Gupta A, Bansal DP, Rijhwani P, Singh V. A case report on acute pancreatitis in a patient with coronavirus disease 2019 (­COVID‑19) pneumonia. Cureus. 2021 Apr 22;13(4):e14628. doi: 10.7759/cureus.14628.

Lei Y, Zhang J, Schiavon CR, He M, et al. SARS‑CoV‑2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021 Apr 30;128(9):1323-6. doi: 10.1161/CIRCRESAHA.121.318902.

Mazrouei SSA, Saeed GA, Al Helali AA. ­COVID‑19-associated acute pancreatitis: a rare cause of acute abdomen. Radiol Case Rep. 2020 Jun 11;15(9):1601-3. doi: 10.1016/j.radcr.2020.06.019.

Muthukrishnan J, Verma AK, Ashta KK, Vardhan V. New-onset diabetes mellitus with ­COVID‑19: Coincidence or cause. Med J Armed Forces India. 2021 Jul;77(Suppl 2):S483-S485. doi: 10.1016/j.mjafi.2021.04.009.

Pandanaboyana S. Exploring Koch’s postulate for SARS‑CoV‑2-induced acute pancreatitis: is it all about the ACE? Br J Surg. 2021 Aug 19;108(8):879-81. doi: 10.1093/bjs/znab178.

Ramkissoon R, Wang XJ. The Impact of ­COVID‑19 in Gastroenterology and Hepatology. J Clin Gastroenterol. 2021 Oct 1;55(9):757-65. doi: 10.1097/MCG.0000000000001600.

Simou EM, Louardi M, Khaoury I, et al. Coronavirus disease-19 (­COVID‑19) associated with acute pancreatitis: case report. Pan Afr Med J. 2020 Oct 13;37 : 150. doi: 10.11604/pamj.2020.37.150.25873.

Stevens JP, Brownell JN, Freeman AJ, Bashaw H. ­COVID‑19-associated multisystem inflammatory syndrome in children presenting as acute pancreatitis. J Pediatr Gastroenterol Nutr. 2020 Nov;71(5):669-71. doi: 10.1097/MPG.0000000000002860.

Susak IaM, Tkachenko OA, Malysh IR, Dirda OO, Fedorchuk OH. [Prognostication of course and treatment of peripancreatic infiltrate in patients, suffering an acute necrotic pancreatitis]. Klin Khir. 2014 Apr;(4):20-2. Ukrainian. PMID: 25097970.

Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2): a systemic infection. Clin Microbiol Rev. 2021 Jan 13;34(2):e00133-20. doi: 10.1128/CMR.00133-20.

Zhi M, Zhu X, Lugea A, et al. Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol. 2019 May 31;10 : 637. doi: 10.3389/fphys.2019.00637.ё

Downloads

Published

2021-12-23

How to Cite

1.
Susak Y, Tkachenko O, Lobanova O, Skivka L. A case report of severe acute pancreatitis with infected necrosis and concomitant Coronavirus Disease‑19 (COVID‑19): a nosocomial infection or delayed respiratory manifestation of viral disease?. ЗХ [Internet]. 2021Dec.23 [cited 2024Dec.9];(1):42—47. Available from: http://generalsurgery.com.ua/article/view/247570

Issue

Section

Clinical Case